Methylprednisolone acetate - Generic Drug Details
What are the generic drug sources for methylprednisolone acetate and what is the scope of freedom to operate?
Methylprednisolone acetate
is the generic ingredient in six branded drugs marketed by Pharmacia And Upjohn, Pfizer, Bel Mar, Amneal, Caplin, Emerge Bioscience, Epic Pharma Llc, Eugia Pharma, Hikma, Ph Health, Sagent Pharms Inc, Sandoz, Teva Pharms Usa, Watson Labs, and Wilshire Pharms Inc, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.Nine suppliers are listed for this compound.
Summary for methylprednisolone acetate
| US Patents: | 0 |
| Tradenames: | 6 |
| Applicants: | 15 |
| NDAs: | 25 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 41 |
| Patent Applications: | 7,749 |
| Drug Prices: | Drug price trends for methylprednisolone acetate |
| What excipients (inactive ingredients) are in methylprednisolone acetate? | methylprednisolone acetate excipients list |
| DailyMed Link: | methylprednisolone acetate at DailyMed |
Recent Clinical Trials for methylprednisolone acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Beijing Tiantan Hospital | PHASE3 |
| Menoufia University | N/A |
| Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |


